Jessica Heck, PharmD, PhD
Acute Care Clinical Pharmacist, Denver VA Medical Center (ECHCS), Denver, CO
Advisor: Dr. Patricia Keely
Graduation: 05/2011
Research Interest: Breast cancer biology, cell signaling
Biography
Alumni News
- In addition to receiving her PhD from the MCP program, Jessica also received her PharmD from the UW–Madison School of Pharmacy. She completed her residency in Pharmacy practice at the Denver VA Medical Center and has accepted a permanent position there. She maintains strong ties to the Keely lab with a continued interest in breast cancer biology and has expanded her interests to include clinical research and patient outcomes.
Publications
-
Fallon MJ, Heck JN (2014). Fatal Stevens-Johnson syndrome/ toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy. J Oncol Pharm Pract. 0(0):1-5. PMID: 25005569
- Heck JN, Ponik SM, Garcia-Mendoza MG, Pehlke CA, Inman DR, Eliceiri KW, and PJ Keely (2012). Microtubules regulate GEF-H1 in response to extracellular matrix stiffness. Mol Biol Cell. 23:2583-2592. PMID: 3386221
- Schramp M, Thapa N, Heck JN, and RA Anderson (2011). PIPKIgamma regulates beta-catenin transcriptional activity downstream of growth factor receptor signaling. Cancer Res. 71:1282-91. PMCID: PMC3066690
- Heck JN, Mellman DL, Ling K, Sun Y, Wagoner MP, Schill NJ, and RA Anderson (2007). A conspicuous connection: structure defines function for the phosphatidylinositol phosphate kinase family. Crit Rev Biochem Mol Biol. 42:15-39. PMID: 17364683